LinkedIn joins as a strategic investor and partner in an oversubscribed secondary round following earlier Series C funding.
"We’re grateful to have LinkedIn’s support and shared vision to provide meaningful connection around the world. LinkedIn is more than just an investor, we are closely collaborating to help LinkedIn members and Hopin users engage with more people and discover immersive experiences. We can’t wait to share more soon as Hopin continues to transform the way we all connect."
Nearly 12,000 retail investors participated in the record-breaking crowdfund to support international expansion and product development.
"Ever since our last crowdfund in 2019, our customers have been requesting another opportunity to take a share in Curve. So we launched this campaign to give the public a chance to join us as we embark on the next stage of our exciting journey, when we reveal Curve Credit to the world and launch in the US. We’ve been blown away by the level of interest we’ve seen over the past three days, and I’m so excited to welcome nearly 12,000 investors on board."
March Capital led the Series C round, which values the enterprise security firm at $500m and brings total funding to over $120m.
"The security of our operations and data is paramount to the success of Arm, and we’re committed to empowering our people to make sound security decisions while doing their jobs effectively. The concept of human layer security is becoming a critical part of doing business today. Tessian enables us to reduce risk across the organization by providing valuable tools and knowledge to not only stop threats like advanced phishing attacks and accidental data loss, but also continually improve the security behaviors of our teams as the threat landscape evolves."
Goldman Sachs Asset Management has backed ComplyAdvantage in an extension to its Series C funding round.
"The company brings clear value to its clients and has grown at an impressive rate. We are excited to support the business as it continues to scale rapidly and help companies of all stages manage these critical risks."
The Series C financing was led by Leaps by Bayer and Hitachi Ventures to support international expansion and platform development.
"This is a pivotal moment in Huma’s development. We have exceptional partners and strategic investors who will support us in our mission to help people worldwide live longer and fuller lives. We’re already demonstrating how ‘hospital at home’ can transform healthcare, and how decentralized clinical trials can advance research in ways that weren’t imaginable even one year ago. Now we want to accelerate the pace of change and continue to innovate for better care and research worldwide."
